Alzheimer’s Curbed By Promising New Drug

A new drug that has completed phase 2 trials in the UK and Singapore is being hailed as a major breakthrough in the treatment of Alzheimer’s, as it appeared to slow the progress of the disease by as much as 81 per cent over a year, compared to placebo. Methylthioninium chloride (MTC) blocks the accumulation of tau protein tangles inside brain cells, one of the principal characteristics of the disease that was originally discovered by Alois Alzheimer 100 years ago.

More: continued here

Filed under: Alzheimer's / Dementia News XML/RSS Feed on July 31st, 2008